Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2021. Start Trial.
Date Value
October 02, 2026 2.800
October 01, 2026 2.783
September 30, 2026 2.870
September 29, 2026 2.862
September 28, 2026 2.835
September 25, 2026 2.923
September 24, 2026 2.853
September 23, 2026 2.870
September 22, 2026 2.862
September 21, 2026 2.809
September 18, 2026 2.862
September 17, 2026 2.818
September 16, 2026 2.652
September 15, 2026 2.660
September 14, 2026 2.686
September 11, 2026 2.739
September 10, 2026 2.713
September 09, 2026 2.879
September 08, 2026 2.774
September 04, 2026 2.730
September 03, 2026 2.695
September 02, 2026 2.686
September 01, 2026 2.608
August 31, 2026 2.625
August 28, 2026 2.634
Date Value
August 27, 2026 2.756
August 26, 2026 2.835
August 25, 2026 2.932
August 24, 2026 2.975
August 21, 2026 2.896
August 20, 2026 2.870
August 19, 2026 2.756
August 18, 2026 2.756
August 17, 2026 2.739
August 14, 2026 2.923
August 13, 2026 2.810
August 12, 2026 2.686
August 11, 2026 2.678
August 10, 2026 2.669
August 07, 2026 2.713
August 06, 2026 2.621
August 05, 2026 2.608
August 04, 2026 2.582
August 03, 2026 2.441
July 31, 2026 2.468
July 30, 2026 2.476
July 29, 2026 2.485
July 28, 2026 2.450
July 27, 2026 2.529
July 24, 2026 2.590

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Autolus Therapeutics Plc 8.446
Cellectis SA 3.506
Akari Therapeutics Plc 0.8208
DBV Technologies SA 3.003
Ascendis Pharma A/S 9.112

Price to Book Value Related Metrics

PS Ratio 3.182
Price 3.20
Earnings Yield -32.92%
Market Cap 26.69M